KPV: Alpha-MSH Fragment Activity, NF-kB Signaling, and Cytokine Suppression Research
KPV is the minimal active tripeptide fragment of alpha-MSH, studied for anti-inflammatory signaling without pigmentation effects, with particular focus on NF-kB inhibition, cytokine suppression, GI inflammation, and wound-healing models.
Abstract
KPV is a short anti-inflammatory tripeptide derived from alpha-MSH. It is researched for retaining core immunomodulatory activity while avoiding pigmentation-associated effects connected to broader melanocortin signaling.
Laboratory interest focuses on inflammatory pathway regulation, cytokine suppression, gastrointestinal inflammation models, and tissue repair environments where excessive inflammatory signaling can slow recovery.
Mechanistic Focus
- NF-kB signaling — studied for its role in reducing inflammatory transcription activity.
- Cytokine suppression — evaluated in models involving TNF-alpha, IL-6, and related inflammatory markers.
- GI and wound-healing models — researched where epithelial stress and inflammatory overload intersect.
Research Use Case
KPV is often selected for focused inflammation research because its short structure allows investigators to study a narrow active fragment without the broader activity profile of the full parent hormone.
Research-Only Notice
The content of this entry is intended exclusively to inform laboratory research and development. The compounds referenced are not intended for human consumption, therapeutic, or diagnostic use.